만성질환 관리 모바일 플랫폼 시장 예측(-2034년) : 질환 유형, 플랫폼 유형, 기능, 도입 모델, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Chronic Disease Management Mobile Platforms Market is accounted for $16.8 billion in 2026 and is expected to reach $52.2 billion by 2034 growing at a CAGR of 15.2% during the forecast period. Chronic Disease Management Mobile Platforms provide digital tools that assist individuals in managing persistent medical conditions using mobile applications and connected technologies. They facilitate health monitoring, medication reminders, symptom recording, individualized care guidance, and interaction with healthcare providers. Many platforms combine information generated by patients with clinical data to support coordinated and timely care. Their applications span diabetes, heart disease, hypertension, respiratory illnesses, and other chronic disorders. Through accessible health resources and self-care features, these platforms encourage active patient participation, improve adherence to treatment routines, and facilitate continuous management of chronic diseases.

According to the World Health Organization (WHO), noncommunicable diseases cause 41 million deaths each year, representing about 71% of all deaths globally. This supports the large underlying need for chronic disease prevention, monitoring, and management solutions.

Market Dynamics:

Driver:

Growing prevalence of chronic diseases

Rising rates of chronic illnesses are encouraging greater adoption of Chronic Disease Management Mobile Platforms because healthcare providers need practical solutions for managing patients beyond hospitals and clinics. Long-term conditions, including diabetes, hypertension, cardiovascular disorders, and respiratory diseases, require consistent monitoring and adherence to treatment plans. Mobile applications enable patients to record symptoms, medications, vital measurements, and daily activities conveniently. By supporting continuous engagement and communication between patients and healthcare professionals, these platforms contribute to sustained disease management while helping healthcare systems address increasing demands efficiently.

Restraint:

Limited digital literacy and technology accessibility

Differences in digital skills and technology access can hinder wider adoption of Chronic Disease Management Mobile Platforms among some populations. Elderly users and people unfamiliar with smartphones or digital healthcare applications may experience difficulties when navigating platform features. Poor internet availability, lack of suitable devices, and affordability issues can further prevent regular participation. Such barriers may weaken engagement with mobile disease management services and reduce their practical benefits, especially in underserved areas where digital infrastructure, device availability, and familiarity with healthcare technologies remain limited.

Opportunity:

Integration with wearable and connected health devices

Connecting Chronic Disease Management Mobile Platforms with wearable and smart healthcare devices can create significant opportunities for broader functionality. Devices such as smartwatches, glucose monitors, blood pressure monitors, activity trackers, and connected sensors can provide regular health measurements through mobile applications. Integrating these readings with patient information can enable individualized monitoring, treatment follow-up, and earlier healthcare responses. This approach can simplify disease management for patients while giving healthcare providers more consistent information. Growing use of connected health technologies creates opportunities for mobile platforms to deliver broader and continuous chronic care support.

Threat:

Rapid technological changes and platform competition

Fast-paced technological development and growing competition in digital healthcare can create challenges for Chronic Disease Management Mobile Platforms. New mobile applications, artificial intelligence solutions, wearable devices, and comprehensive healthcare ecosystems are continually being introduced, increasing expectations for advanced features and convenient experiences. Platforms that fail to update their functionality or support newer technologies may lose relevance over time. Competitive pressure can also affect pricing, user retention, and investment needs. Developers and healthcare providers therefore need ongoing innovation to maintain platform usefulness as technology and patient expectations continue to change.

Covid-19 Impact:

COVID-19 increased the use of Chronic Disease Management Mobile Platforms by encouraging healthcare providers to deliver care remotely during disruptions to regular medical services. People managing chronic illnesses needed ongoing support while reducing unnecessary visits to healthcare facilities. Mobile applications enabled remote interaction, health monitoring, symptom reporting, and medication management, helping maintain treatment continuity. The pandemic further prompted healthcare organizations to strengthen telehealth infrastructure and digital care services. As a result, awareness of mobile healthcare solutions expanded, supporting their broader integration into long-term chronic disease management practices.

The diabetes management platforms segment is expected to be the largest during the forecast period

The diabetes management platforms segment is expected to account for the largest market share during the forecast period because diabetes requires regular monitoring and active patient participation in everyday care. These solutions provide tools for blood glucose tracking, medication management, nutrition monitoring, exercise guidance, and personalized recommendations. They can also connect patients with healthcare professionals for ongoing supervision and treatment support. Integration with connected glucose-monitoring technologies further enhances their usefulness, making mobile platforms valuable for delivering convenient, continuous, and comprehensive support for individuals managing diabetes over the long term.

The employers & wellness program providers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the employers & wellness program providers segment is predicted to witness the highest growth rate as businesses increasingly use digital solutions to support workforce health and long-term condition management. Mobile platforms can deliver personalized wellness guidance, health tracking, lifestyle recommendations, medication assistance, and preventive healthcare resources. Their use within workplace wellness programs helps organizations promote healthier habits and ongoing disease management. Increasing emphasis on employee engagement, preventive healthcare, and digitally enabled wellness initiatives is creating expanding opportunities for mobile platforms focused on chronic disease support.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by developed digital health infrastructure, high technology adoption, and established remote-care capabilities. The significant prevalence of chronic conditions encourages demand for convenient tools that support ongoing monitoring and self-management. Healthcare organizations increasingly incorporate digital solutions into patient care beyond conventional clinical environments. A strong ecosystem of healthcare providers, technology developers, and digital health initiatives also supports the integration and use of mobile platforms for managing chronic diseases throughout the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by expanding smart phone usage, improving digital healthcare infrastructure, and increasing demand for remote care. The rising prevalence of chronic conditions is encouraging providers to adopt mobile solutions for monitoring and ongoing disease management. Government digital-health programs, better connectivity, and growing telehealth utilization are contributing to regional development. Increasing investment in healthcare technologies and improving awareness among patients are also creating opportunities for mobile platforms to become more integrated into long-term chronic care.

Key players in the market

Some of the key players in Chronic Disease Management Mobile Platforms Market include Teladoc Health, Omada Health, DarioHealth, Welldoc, Hinge Health, Medtronic, Abbott, Roche, Dexcom, ResMed, Liva Healthcare, Health2Sync, Vida Health, Virta Health, Hello Heart, SWORD Health, HealthSnap and Twin Health.

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In January 2026, Teladoc Health announced the launch of new enhancements to its 24/7 Care service. The new capabilities build on the company's flagship virtual urgent care service which provides access to licensed care providers who assess and treat non-emergency medical needs, 24 hours a day, seven days a week.

In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.

Disease Types Covered:

• Diabetes Management Platforms
• Cardiovascular Disease Management Platforms
• Respiratory Disease Management Platforms
• Oncology Management Platforms
• Neurological Disorder Management Platforms
• Other Chronic Conditions

Platform Types Covered:

• Smartphone Applications
• Tablet Applications
• Web-based Platforms
• Wearable-integrated Platforms

Functionalities Covered:

• Patient Self-Management & Monitoring
• Medication Adherence & Reminders
• Remote Clinical Monitoring & Teleconsultation
• Data Analytics & Predictive Insights
• Lifestyle & Behavioural Coaching

Deployment Models Covered:

• Cloud-based Platforms
• On-premise Platforms

End Users Covered:

• Patients & Caregivers
• Healthcare Providers
• Payers & Insurance Companies
• Employers & Wellness Program Providers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Chronic Disease Management Mobile Platforms Market, By Disease Type

• 5.1 Diabetes Management Platforms
• 5.2 Cardiovascular Disease Management Platforms
• 5.3 Respiratory Disease Management Platforms
• 5.4 Oncology Management Platforms
• 5.5 Neurological Disorder Management Platforms
• 5.6 Other Chronic Conditions

6 Global Chronic Disease Management Mobile Platforms Market, By Platform Type

• 6.1 Smartphone Applications
• 6.2 Tablet Applications
• 6.3 Web-based Platforms
• 6.4 Wearable-integrated Platforms

7 Global Chronic Disease Management Mobile Platforms Market, By Functionality

• 7.1 Patient Self-Management & Monitoring
• 7.2 Medication Adherence & Reminders
• 7.3 Remote Clinical Monitoring & Teleconsultation
• 7.4 Data Analytics & Predictive Insights
• 7.5 Lifestyle & Behavioural Coaching

8 Global Chronic Disease Management Mobile Platforms Market, By Deployment Model

• 8.1 Cloud-based Platforms
• 8.2 On-premise Platforms

9 Global Chronic Disease Management Mobile Platforms Market, By End User

• 9.1 Patients & Caregivers
• 9.2 Healthcare Providers
• 9.3 Payers & Insurance Companies
• 9.4 Employers & Wellness Program Providers

10 Global Chronic Disease Management Mobile Platforms Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Teladoc Health
• 13.2 Omada Health
• 13.3 DarioHealth
• 13.4 Welldoc
• 13.5 Hinge Health
• 13.6 Medtronic
• 13.7 Abbott
• 13.8 Roche
• 13.9 Dexcom
• 13.10 ResMed
• 13.11 Liva Healthcare
• 13.12 Health2Sync
• 13.13 Vida Health
• 13.14 Virta Health
• 13.15 Hello Heart
• 13.16 SWORD Health
• 13.17 HealthSnap
• 13.18 Twin Health